cyclopentane has been researched along with Plasma Cell Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mestroni, G; Monti-Bragadin, C; Saincich, G; Tamaro, M; Venturini, S; Zassinovich, G | 1 |
| Jarman, M; Kuszmann, J; Stock, JA | 1 |
2 other study(ies) available for cyclopentane and Plasma Cell Tumor
| Article | Year |
|---|---|
Effects in bacterial systems of Pt(II) complexes with antitumour activity.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclobutanes; Cyclohexylamines; Cyclopentanes; DNA Repair; DNA, Bacterial; Drug Evaluation, Preclinical; Escherichia coli; Leukemia L1210; Mutagens; Plasmacytoma; Salmonella typhimurium; Structure-Activity Relationship | 1979 |
Aminoacyl nucleosides derived from the tumour inhibitor, 1-aminocyclopentanecarboxylic acid.
Topics: Aluminum; Amino Acids; Animals; Antineoplastic Agents; Benzyl Compounds; Carbon Isotopes; Catalysis; Chemical Phenomena; Chemistry; Chromatography, Paper; Chromatography, Thin Layer; Cyclopentanes; Drug Stability; Electrophoresis; Escherichia coli; Esters; Half-Life; Hydrogen; Hydrolysis; Leucine; Magnetic Resonance Spectroscopy; Mice; Neoplasms, Experimental; Nucleosides; Oxidation-Reduction; Oxides; Plasmacytoma; Protein Biosynthesis; Stereoisomerism; Tritium; Uridine; Valine | 1969 |